Fang Dou
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Natural product bioactivities and synthesis 2
-
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Aidong Wen (10 shared papers)Yi Ding (8 shared papers)Jingwen Wang (3 shared papers)Lin Chen (2 shared papers)Hua Chen (2 shared papers)Ying‐Yong Zhao (2 shared papers)Tianlong Liu (5 shared papers)Xiangrong Tian (2 shared papers)
- Journals
- Rejuvenation Research (3 papers)Biochemical Pharmacology (1 paper)Fitoterapia (1 paper)Chemico-Biological Interactions (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Fang Dou
15 papers receiving 515 citations
Peers
Comparison fields: 5 of 77
- Nephrology 89
- Complementary and alternative medicine 77
- Pharmacology 47
- Biochemistry 27
- Pharmacology 54
Countries citing papers authored by Fang Dou
This map shows the geographic impact of Fang Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Dou more than expected).
Fields of papers citing papers by Fang Dou
This network shows the impact of papers produced by Fang Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Dou. The network helps show where Fang Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Fang Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 90 | |
| 2 | 2018 | 86 | |
| 3 | 2018 | 52 | |
| 4 | 2019 | 52 | |
| 5 | 2011 | 50 | |
| 6 | 2020 | 44 | |
| 7 | 2017 | 31 | |
| 8 | alpha-Glucosidase and alpha-amylase inhibitory activities of saponins from traditional Chinese medicines in the treatment of diabetes mellitus. | 2013 | 27 |
| 9 | 2013 | 20 | |
| 10 | 2013 | 19 | |
| 11 | 2018 | 18 | |
| 12 | 2017 | 17 | |
| 13 | 2019 | 11 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 |
About Fang Dou
Fang Dou is a scholar working on Molecular Biology, Nephrology, Pharmacology, Complementary and alternative medicine and Pathology and Forensic Medicine, having authored 15 papers that have together received 519 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Biological Stains and Phytochemicals (2 papers), Cardiac Valve Diseases and Treatments (2 papers), Natural product bioactivities and synthesis (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Phytochemicals and Medicinal Plants (2 papers) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Nephrology (89 citations), Complementary and alternative medicine (77 citations), Pharmacology (47 citations), Biochemistry (27 citations) and Pharmacology (54 citations). Fang Dou has collaborated with scholars based in China and United States. Frequent co-authors include Aidong Wen, Yi Ding, Jingwen Wang, Lin Chen, Hua Chen, Ying‐Yong Zhao, Tianlong Liu, Xiangrong Tian, Ming Wang and Wenjun Wang. Their work appears in journals such as Rejuvenation Research, Biochemical Pharmacology, Fitoterapia, Chemico-Biological Interactions and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.